These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10441502)
1. Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion. Kitaguchi T; Murata M; Iijima K; Kamide K; Imagawa T; Ikeda Y Biochem Biophys Res Commun; 1999 Aug; 261(3):784-9. PubMed ID: 10441502 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727 [TBL] [Abstract][Full Text] [Related]
3. Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions. Nishiya T; Murata M; Handa M; Ikeda Y Biochem Biophys Res Commun; 2000 Apr; 270(3):755-60. PubMed ID: 10772897 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion. Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614 [TBL] [Abstract][Full Text] [Related]
5. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease. Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443 [TBL] [Abstract][Full Text] [Related]
6. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox. Wu WB; Peng HC; Huang TF Thromb Haemost; 2001 Dec; 86(6):1501-11. PubMed ID: 11776320 [TBL] [Abstract][Full Text] [Related]
7. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. Kang M; Wilson L; Kermode JC Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030 [TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Ulrichts H; Vanhoorelbeke K; Cauwenberghs S; Vauterin S; Kroll H; Santoso S; Deckmyn H Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1302-7. PubMed ID: 12775575 [TBL] [Abstract][Full Text] [Related]
10. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340 [TBL] [Abstract][Full Text] [Related]
11. The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding. Dong JF; Li CQ; Sae-Tung G; Hyun W; Afshar-Kharghan V; López JA Biochemistry; 1997 Oct; 36(41):12421-7. PubMed ID: 9376345 [TBL] [Abstract][Full Text] [Related]
12. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding. Li CQ; Dong JF; López JA Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242 [TBL] [Abstract][Full Text] [Related]
13. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells. Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479 [TBL] [Abstract][Full Text] [Related]
14. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species. Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169 [TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of transgenic mice expressing human platelet glycoprotein Ib alpha. Kitaguchi T; Murata M; Kuramochi T; Kobayashi K; Ito M; Ueyama Y; Nomura T; Hikichi K; Miyakawa Y; Handa M; Hiraoka Y; Aiso S; Ikeda Y Biochem Biophys Res Commun; 1996 Mar; 220(2):418-24. PubMed ID: 8645320 [TBL] [Abstract][Full Text] [Related]
17. Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex. Graham SS; Gonchoroff NJ; Miller JL Am J Clin Pathol; 2001 Jan; 115(1):144-7. PubMed ID: 11190800 [TBL] [Abstract][Full Text] [Related]
18. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor. Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505 [TBL] [Abstract][Full Text] [Related]
19. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951 [TBL] [Abstract][Full Text] [Related]
20. Expression of the amino-terminal domain of platelet glycoprotein Ib alpha: exploitation of a calmodulin tag for determination of its functional activity. Li CQ; Ye P; Cao Zf ; Wang H; Lu L; Nicastro P; Wood E; Robert JJ; Ouwehand WH; Hill F; López JA; Wardell MR Protein Expr Purif; 2001 Jul; 22(2):200-10. PubMed ID: 11437595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]